![]() |
市場調查報告書
商品編碼
1959303
2026 年至 2035 年機能性食品市場中後生元成分的成長要素、產業趨勢和預測。Postbiotic Ingredients in Functional Foods Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
2025 年,全球機能性食品用後生元成分市場價值為 5.974 億美元,預計到 2035 年將以 11.3% 的複合年成長率成長至 17.4 億美元。

這一成長主要得益於消費者對腸道健康和微生物組科學的日益關注,以及對穩定性高、易於配製的功能性成分需求的不斷成長。後生元成分使食品生產商能夠在不製作流程和儲存過程中維持活性菌群所帶來的配方難題的情況下,提供與微生物組相關的益處。因此,越來越多的品牌開始採用後生元作為益生菌的低風險替代品,同時保持其在消化健康和免疫支持方面的強大市場地位。關鍵地區的監管政策細化以及以營養價值和便利性為優先考慮的食品形式的融合,正在加速產品創新。消費者對發酵食品和有益腸道產品的廣泛興趣進一步增強了市場需求,生產商正在開發涵蓋多個品類的微生物組支持配方。耐熱後生元成分的應用正在不斷增加,尤其是在傳統活性菌叢穩定性難以保證的應用中。消費者對消化健康的日益成長且可量化的興趣將繼續支撐市場的長期擴張。
| 市場範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測年份 | 2026-2035 |
| 起始值 | 5.974億美元 |
| 預測金額 | 17.4億美元 |
| 複合年成長率 | 11.3% |
預計到2025年,胜肽和蛋白質細分市場將佔據22%的市場佔有率,並在2035年之前以12.2%的複合年成長率成長。原料供應商正從提供單一成分轉向提供多功能混合物,這些混合物結合了胜肽、酵素、細胞組分、維生素和其他生物活性化合物。這些解決方案以標準化標籤為目標,定位為配料,旨在提供穩定的效力、更佳的風味和更高的生產效率。在商業策略中,跨品類相容性日益重要,這使得這些產品能夠應用於乳製品、飲料和零食配方,同時支持差異化的功能性宣稱,並輔以穩定性檢驗和文件記錄。
預計到2025年,乳製品和發酵乳製品市場佔有率將達到38%,到2035年將以10.9%的複合年成長率成長。該細分市場之所以維持核心地位,是因為其發酵帶來的健康益處以及與消費者既有消費習慣的天然親和性。製造商正在將後生元成分添加到各種乳製品中,以提高配方穩定性,確保產品功能始終如一,同時又不影響消費者的感官體驗。在維持傳統口味的同時,增強消化健康訊息,此優勢持續推動著此品類的市場成長。
預計到2025年,北美機能性食品用後生元成分市場規模將達到1.569億美元,到2035年將達到4.604億美元,主要得益於主流腸道健康機能性食品的強勁創新。美國憑藉其成熟的機能性食品品牌和原料供應商生態系統,正引領區域成長。市場擴張的促進因素包括:膳食補充劑概念在食品飲料行業的跨界應用、消化健康產品零售分銷網路的拓展,以及消費者對便捷攜帶式產品形式的高度認可。
(註:貿易統計數據僅涵蓋主要國家。)
The Global Postbiotic Ingredients in Functional Foods Market was valued at USD 597.4 million in 2025 and is estimated to grow at a CAGR of 11.3% to reach USD 1.74 billion by 2035.

Growth is driven by rising consumer awareness of gut health and microbiome science, alongside increasing demand for stable and easy-to-formulate functional ingredients. Postbiotic ingredients offer food manufacturers the ability to deliver microbiome-related benefits without the formulation challenges linked to maintaining live cultures during processing and shelf life. As a result, brands are increasingly turning to postbiotics as a lower-risk alternative to probiotics while maintaining strong positioning around digestive health and immune support. Regulatory clarity in key regions, combined with the convergence of nutrition and convenience-driven food formats, is accelerating product innovation. Broader interest in fermented and gut-friendly products has further strengthened demand, with manufacturers developing microbiome-supportive formulations across multiple categories. Heat-stable postbiotic ingredients are gaining traction, particularly in applications where traditional live cultures face stability limitations. Quantifiable consumer interest in digestive wellness continues to support long-term market expansion.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $597.4 Million |
| Forecast Value | $1.74 Billion |
| CAGR | 11.3% |
The peptides and proteins segment accounted for 22% share in 2025 and is expected to grow at a CAGR of 12.2% through 2035. Ingredient suppliers are moving beyond single-component offerings toward multifunctional blends that combine peptides, enzymes, cell fractions, vitamins, and additional bioactive compounds. These solutions are positioned as standardized, label-friendly ingredients that deliver consistent potency, improved flavor profiles, and greater manufacturing efficiency. Commercial strategies increasingly emphasize cross-category compatibility, enabling use across dairy, beverage, and snack formulations while supporting differentiated functional claims backed by stability validation and documentation.
The dairy and fermented dairy applications segment held 38% share in 2025 and is forecast to grow at a CAGR of 10.9% by 2035. This segment remains central due to its natural alignment with fermentation-based health narratives and established consumption habits. Manufacturers are incorporating postbiotic ingredients into a wide range of dairy-based products to enhance formulation stability and ensure consistent functional positioning without compromising sensory expectations. The ability to reinforce digestive health messaging while maintaining traditional taste profiles continues to strengthen adoption within this category.
North America Postbiotic Ingredients in Functional Foods Market accounted for USD 156.9 million in 2025 and is projected to reach USD 460.4 million by 2035, supported by strong innovation in mainstream gut-health functional foods. The United States leads regional growth through a well-developed ecosystem of functional food brands and ingredient suppliers. Market expansion benefits from the crossover of dietary supplement concepts into food and beverage applications, widespread retail availability of digestive wellness products, and high consumer acceptance of convenient, on-the-go functional formats.
Key companies operating in the Global Postbiotic Ingredients in Functional Foods Market include DSM-Firmenich, IFF (International Flavors & Fragrances), ADM, Kerry Group, BASF, Novonesis, Cargill, Givaudan, Evonik, and DuPont (IFF legacy Danisco). Companies in the Postbiotic Ingredients in Functional Foods Market are strengthening their competitive position through targeted research and development, strategic partnerships with food manufacturers, and portfolio diversification. Many players are investing in clinically supported formulations to substantiate claims related to digestive and immune health. Expanding multifunctional ingredient blends enhances cross-category application flexibility and improves formulation efficiency for brand owners. Firms are also prioritizing regulatory alignment and clean-label positioning to meet evolving consumer expectations. Strategic acquisitions and collaborations are enabling companies to broaden their geographic reach and accelerate innovation pipelines.
( Note: the trade statistics will be provided for key countries only)